Immunocine Cancer Center
Houston, Texas, United States · Biotechnology, Health Care, Medical
Immunocine Cancer Center is advancing a personalized approach to cancer treatment through its proprietary dendritic cell immunotherapy platform. The organization focuses on innovative therapies in cancer immunotherapy and translational medicine. With a commitment to scientific excellence, Immunocine aims to make a meaningful difference in the lives of cancer patients and their families.
Key facts
- Headquarters
- Houston, Texas, United States
- Employees
- 25
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- immunocine.com
- Company page
Recent activity at Immunocine Cancer Center
Leadership
- Vita, Executive Director of Operations
- Vita S. Salsman, Executive Director
Verified email and direct lines for Immunocine Cancer Center’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Immunocine Cancer Center in the news
- Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director - Business Wire (Jul 07, 2026)
- Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer - Yahoo Finance (Aug 10, 2026)
- Immunocine Cancer Center Expands as Demand Grows for Personalized Dendritic Cell Therapy - GlobeNewswire (Aug 18, 2026)
- Immunocine Names Janet Maendel, DO (EU), DNM, Director of Clinical Affairs - GlobeNewswire (Sep 29, 2026)
Companies similar to Immunocine Cancer Center
- Aethlon Medical · Biotechnology, Health Care, Medical, Therapeutics
- Faeth Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- NuCana · Biotechnology, Health Care, Medical, Therapeutics
- Imugene · Biotechnology, Health Care, Medical, Therapeutics
- OncoNano Medicine · Biotechnology, Health Care, Medical, Therapeutics
About Immunocine Cancer Center: questions and answers
What does Immunocine Cancer Center do?
Immunocine Cancer Center is advancing a personalized approach to cancer treatment through its proprietary dendritic cell immunotherapy platform. The organization focuses on innovative therapies in cancer immunotherapy and translational medicine. With a commitment to scientific excellence, Immunocine aims to make a meaningful difference in the lives of cancer patients and their families.
Where is Immunocine Cancer Center headquartered?
Immunocine Cancer Center is headquartered in Houston, Texas, United States.
How many employees does Immunocine Cancer Center have?
Immunocine Cancer Center has about 25 employees.
What is the latest news on Immunocine Cancer Center?
On Jul 07, 2026, Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy